alpha-1 proteinase inhibitor
Selected indexed studies
- Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. (Amino Acids, 2006) [PMID:16773239]
- Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor. (Am J Physiol, 1994) [PMID:8023948]
- The elastase/alpha 1-proteinase inhibitor balance in the lung. A review. (Schweiz Med Wochenschr, 1984) [PMID:6379867]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. (2006) pubmed
- Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor. (1994) pubmed
- The elastase/alpha 1-proteinase inhibitor balance in the lung. A review. (1984) pubmed
- Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation. (1996) pubmed
- Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. (2017) pubmed
- Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis. (2023) pubmed
- Bioengineering: alpha 1-proteinase inhibitor site-specific mutagenesis. The prospect for improving the inhibitor. (1996) pubmed
- Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature. (2017) pubmed
- Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms. (1995) pubmed
- Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy. (2017) pubmed